Carregant...

Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy

By analyzing over 2000 samples from a randomized clinical trial, we have recently associated high levels of tumor-infiltrating lymphocytes with an excellent prognosis among triple negative breast cancer patients as well with improved clinical responses to immunogenic chemotherapy among patients bear...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Loi, Sherene
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3782009/
https://ncbi.nlm.nih.gov/pubmed/24073365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24720
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!